Application

16206010 · 3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

Filed 2018-11-30 · Abandoned The official file ↗ · Art unit 1626 · Examiner Laura Lynne Stockton Typical · CPC C07D 487/04 · Boston Biomedical, Inc. · Boston Biomedical, Inc. / SLW

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

7.3 mo

to disposition 13.8 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.